This melatonin modulatory effect on the aromatase and sulfatase enzymes, at the tumor cell level, has also been described in vivo, in rats bearing 7,12-dimethylbenzanthracene-induced mammary tumors. This evidence concerns the gene CYP19A1 and neoplasm.